Eralp Levent, Bilen F Erkal, Rozbruch S Robert, Kocaoglu Mehmet, Hammoudi Ahmed I
Department of Orthopaedics and Traumatology, Istanbul Faculty of Medicine, Istanbul University, 34390, Topkapi, Istanbul, Turkey.
Department of Orthopaedics and Traumatology, Memorial Health Group, 34385, Okmeydani, Istanbul, Turkey.
Strategies Trauma Limb Reconstr. 2016 Apr;11(1):37-49. doi: 10.1007/s11751-016-0244-8. Epub 2016 Feb 12.
The mechanical features of and biologic response to using distraction osteogenesis with the circular external fixator are the unique aspects of Ilizarov's contribution that allows deformity correction and reconstruction of bone defects. We present a retrospective study of 20 patients who suffered from a variety of benign tumours for which external fixators (EF) were used to treat deformity, bone loss, and limb-length discrepancy. A total of 26 bony segments in twenty patients (10 males, 10 females; mean age 17 years; range 7-58 years) were treated with EF for residual problems from the tumour itself (primary treatment) in 8 patients and for complications related to the primary surgery (secondary treatment) in 12 patients. Histological diagnoses were Ollier's disease (n = 4), Fibrous Dysplasia (n = 5), Congenital multiple exostosis (n = 5), giant cell tumour (n = 2) and one case for chondromyxoid fibroma, desmoid fibroma, chondroma and unicameral bone cyst. Various types of external fixators used to treat these problems. These were Ilizarov, unilateral fixator, multiaxial correction frame (Biomet, Parsippany, NJ), Taylor spatial frame (Memphis, TN) and smart correction multiaxial frame. The mean follow-up time was 69.5 months (range 35-108 months). The mean external fixation time was 159.5 days (range 27-300 days). The mean external fixation index was 67.4 days/cm (12-610) in 26 limbs who underwent distraction osteogenesis. The mean length of distraction was 4.9 cm (range 0.2-14 cm). At final follow-up, all patients had returned to normal activities. Complications were in the form of knee arthrodesis in one patient, pin tract infection in six and residual shortening in eight patients. The use of EF and the principles of distraction osteogenesis, in the management of problems associated with benign bone tumours and related surgery yields successful results especially in young patients. With this approach, the risk for recurrence of shortening and deformity may be minimized with overcorrection or over-lengthening as dictated by preoperative planning.
使用环形外固定器进行牵张成骨的力学特性及生物学反应,是伊里扎洛夫贡献的独特之处,它能够实现畸形矫正和骨缺损重建。我们对20例患有各种良性肿瘤的患者进行了一项回顾性研究,这些患者使用外固定器(EF)治疗畸形、骨丢失和肢体长度差异。20例患者(10例男性,10例女性;平均年龄17岁;范围7 - 58岁)共26个骨段接受了EF治疗,其中8例用于治疗肿瘤本身的残留问题(初次治疗),12例用于治疗与初次手术相关的并发症(二次治疗)。组织学诊断为 Ollier 病(n = 4)、纤维发育不良(n = 5)、先天性多发性骨软骨瘤(n = 5)、骨巨细胞瘤(n = 2),还有1例为黏液样纤维瘤、硬纤维瘤、软骨瘤和单房性骨囊肿。使用了各种类型的外固定器来治疗这些问题。这些外固定器包括伊里扎洛夫外固定器、单侧固定器、多轴矫正架(Biomet,帕西帕尼,新泽西州)、泰勒空间架(孟菲斯,田纳西州)和智能矫正多轴架。平均随访时间为69.5个月(范围35 - 108个月)。平均外固定时间为159.5天(范围27 - 300天)。在26例接受牵张成骨的肢体中,平均外固定指数为67.4天/cm(12 - 610)。平均牵张长度为4.9 cm(范围0.2 - 14 cm)。在最后随访时,所有患者均恢复了正常活动。并发症包括1例患者出现膝关节融合、6例患者出现针道感染以及8例患者出现残留短缩。在处理与良性骨肿瘤及相关手术有关的问题时,使用EF及牵张成骨原则可取得成功结果,尤其在年轻患者中。通过这种方法,根据术前规划进行过度矫正或过度延长,可将缩短和畸形复发的风险降至最低。